PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mecp2
|
ENSMUSG00000031393.17 | Mecp2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Mecp2 | mm39_v1_chrX_-_73129195_73129296 | 0.44 | 9.0e-05 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_4412546 | 9.75 |
ENSMUST00000014447.13
|
Glis2
|
GLIS family zinc finger 2 |
chr10_+_79824418 | 8.58 |
ENSMUST00000004784.11
ENSMUST00000105374.2 |
Cnn2
|
calponin 2 |
chr11_-_75918551 | 8.18 |
ENSMUST00000021207.7
|
Rflnb
|
refilin B |
chr11_+_98303287 | 7.92 |
ENSMUST00000058295.6
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2 |
chr9_-_44792575 | 7.90 |
ENSMUST00000114689.8
ENSMUST00000002095.11 ENSMUST00000128768.3 |
Kmt2a
|
lysine (K)-specific methyltransferase 2A |
chr17_-_7050145 | 7.75 |
ENSMUST00000064234.7
|
Ezr
|
ezrin |
chr9_+_92424276 | 7.73 |
ENSMUST00000070522.14
ENSMUST00000160359.2 |
Plod2
|
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
chr2_-_69416365 | 7.58 |
ENSMUST00000100051.9
ENSMUST00000092551.5 ENSMUST00000080953.12 |
Lrp2
|
low density lipoprotein receptor-related protein 2 |
chr16_-_76169902 | 7.30 |
ENSMUST00000054178.8
|
Nrip1
|
nuclear receptor interacting protein 1 |
chr11_-_100861713 | 7.25 |
ENSMUST00000060792.6
|
Cavin1
|
caveolae associated 1 |
chr11_-_120239301 | 6.85 |
ENSMUST00000062147.14
ENSMUST00000128055.2 |
Actg1
|
actin, gamma, cytoplasmic 1 |
chr15_-_85918378 | 6.74 |
ENSMUST00000016172.10
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 |
chr15_+_80057894 | 6.68 |
ENSMUST00000044970.7
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chr8_+_72889073 | 6.62 |
ENSMUST00000003575.11
|
Tpm4
|
tropomyosin 4 |
chr19_-_47907705 | 6.56 |
ENSMUST00000095998.7
|
Itprip
|
inositol 1,4,5-triphosphate receptor interacting protein |
chr8_+_12807001 | 6.52 |
ENSMUST00000033818.10
ENSMUST00000091237.12 |
Atp11a
|
ATPase, class VI, type 11A |
chr2_+_164404499 | 6.51 |
ENSMUST00000017867.10
ENSMUST00000109344.9 ENSMUST00000109345.9 |
Wfdc2
|
WAP four-disulfide core domain 2 |
chrX_+_72716756 | 6.35 |
ENSMUST00000033752.14
ENSMUST00000114467.9 |
Slc6a8
|
solute carrier family 6 (neurotransmitter transporter, creatine), member 8 |
chr17_+_36132567 | 6.35 |
ENSMUST00000003635.7
|
Ier3
|
immediate early response 3 |
chr11_-_68277631 | 6.28 |
ENSMUST00000021284.4
|
Ntn1
|
netrin 1 |
chr15_+_95688763 | 6.26 |
ENSMUST00000227791.2
|
Ano6
|
anoctamin 6 |
chr2_-_104680104 | 6.26 |
ENSMUST00000028593.11
|
Prrg4
|
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
chr16_+_33504740 | 6.22 |
ENSMUST00000232568.2
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr15_-_79326001 | 6.09 |
ENSMUST00000122044.8
ENSMUST00000135519.2 |
Csnk1e
|
casein kinase 1, epsilon |
chr9_+_118435755 | 6.09 |
ENSMUST00000044165.14
|
Itga9
|
integrin alpha 9 |
chr5_+_103902426 | 5.86 |
ENSMUST00000153165.8
ENSMUST00000031256.6 |
Aff1
|
AF4/FMR2 family, member 1 |
chr4_+_137004793 | 5.86 |
ENSMUST00000045747.5
|
Wnt4
|
wingless-type MMTV integration site family, member 4 |
chr3_+_122523219 | 5.84 |
ENSMUST00000200389.2
|
Pde5a
|
phosphodiesterase 5A, cGMP-specific |
chr15_-_79326200 | 5.75 |
ENSMUST00000117786.9
ENSMUST00000120859.9 |
Csnk1e
|
casein kinase 1, epsilon |
chr5_+_64250268 | 5.70 |
ENSMUST00000087324.7
|
Pgm2
|
phosphoglucomutase 2 |
chr19_-_56996617 | 5.65 |
ENSMUST00000118800.8
ENSMUST00000111584.9 ENSMUST00000122359.8 ENSMUST00000148049.8 |
Afap1l2
|
actin filament associated protein 1-like 2 |
chr2_-_104679838 | 5.65 |
ENSMUST00000126824.2
|
Prrg4
|
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
chr9_-_90152759 | 5.64 |
ENSMUST00000041767.14
ENSMUST00000128874.3 |
Tbc1d2b
|
TBC1 domain family, member 2B |
chr2_+_71617402 | 5.58 |
ENSMUST00000238991.2
|
Itga6
|
integrin alpha 6 |
chr1_-_74163575 | 5.54 |
ENSMUST00000169786.8
ENSMUST00000212888.2 ENSMUST00000191104.7 |
Tns1
|
tensin 1 |
chr10_+_99851679 | 5.53 |
ENSMUST00000130190.8
ENSMUST00000218200.2 ENSMUST00000020129.8 |
Kitl
|
kit ligand |
chr12_-_25146078 | 5.44 |
ENSMUST00000222667.2
ENSMUST00000020974.7 |
Id2
|
inhibitor of DNA binding 2 |
chr7_+_86895851 | 5.41 |
ENSMUST00000032781.14
|
Nox4
|
NADPH oxidase 4 |
chr11_-_120239339 | 5.38 |
ENSMUST00000071555.13
|
Actg1
|
actin, gamma, cytoplasmic 1 |
chr8_+_72889607 | 5.33 |
ENSMUST00000238492.2
|
Tpm4
|
tropomyosin 4 |
chr4_-_133360749 | 5.28 |
ENSMUST00000084238.5
|
Zdhhc18
|
zinc finger, DHHC domain containing 18 |
chr2_-_65068960 | 5.24 |
ENSMUST00000112429.9
ENSMUST00000102726.8 ENSMUST00000112430.8 |
Cobll1
|
Cobl-like 1 |
chr1_-_155120190 | 5.19 |
ENSMUST00000186156.7
|
BC034090
|
cDNA sequence BC034090 |
chr2_-_25255650 | 5.17 |
ENSMUST00000102925.4
|
Uap1l1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
chr3_+_96465265 | 5.12 |
ENSMUST00000074519.13
ENSMUST00000049093.8 |
Txnip
|
thioredoxin interacting protein |
chr8_+_27575611 | 5.09 |
ENSMUST00000178514.8
ENSMUST00000033876.14 |
Adgra2
|
adhesion G protein-coupled receptor A2 |
chr2_-_65068917 | 5.09 |
ENSMUST00000090896.10
ENSMUST00000155082.2 |
Cobll1
|
Cobl-like 1 |
chr18_+_50112494 | 5.04 |
ENSMUST00000148989.3
|
Tnfaip8
|
tumor necrosis factor, alpha-induced protein 8 |
chr17_+_44499451 | 4.96 |
ENSMUST00000024755.7
|
Clic5
|
chloride intracellular channel 5 |
chr13_-_73848807 | 4.94 |
ENSMUST00000022048.6
|
Slc6a19
|
solute carrier family 6 (neurotransmitter transporter), member 19 |
chr11_-_52174129 | 4.94 |
ENSMUST00000109071.3
|
Tcf7
|
transcription factor 7, T cell specific |
chr16_+_33504908 | 4.90 |
ENSMUST00000126532.2
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr11_-_116001037 | 4.90 |
ENSMUST00000106441.8
ENSMUST00000021120.6 |
Trim47
|
tripartite motif-containing 47 |
chr5_-_98178834 | 4.89 |
ENSMUST00000199088.2
|
Antxr2
|
anthrax toxin receptor 2 |
chr1_+_39940189 | 4.85 |
ENSMUST00000191761.6
ENSMUST00000193682.6 ENSMUST00000195860.6 ENSMUST00000195259.6 ENSMUST00000195636.6 ENSMUST00000192509.6 |
Map4k4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr17_+_73225292 | 4.81 |
ENSMUST00000024857.14
|
Lbh
|
limb-bud and heart |
chr5_-_96309600 | 4.74 |
ENSMUST00000129646.8
ENSMUST00000113005.9 ENSMUST00000154500.2 ENSMUST00000141383.8 |
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr4_+_47091909 | 4.74 |
ENSMUST00000045041.12
ENSMUST00000107744.2 |
Galnt12
|
polypeptide N-acetylgalactosaminyltransferase 12 |
chr11_-_117671436 | 4.74 |
ENSMUST00000026659.10
ENSMUST00000127227.2 |
Tmc6
|
transmembrane channel-like gene family 6 |
chr11_+_53660834 | 4.70 |
ENSMUST00000108920.10
ENSMUST00000140866.9 ENSMUST00000108922.9 |
Irf1
|
interferon regulatory factor 1 |
chr5_+_103902020 | 4.61 |
ENSMUST00000054979.10
|
Aff1
|
AF4/FMR2 family, member 1 |
chr8_-_58106027 | 4.59 |
ENSMUST00000110316.3
|
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7 |
chr9_-_110572721 | 4.58 |
ENSMUST00000166716.8
|
Pth1r
|
parathyroid hormone 1 receptor |
chr8_+_84724130 | 4.54 |
ENSMUST00000095228.5
|
Samd1
|
sterile alpha motif domain containing 1 |
chr17_+_28547445 | 4.52 |
ENSMUST00000042334.16
|
Rpl10a
|
ribosomal protein L10A |
chr3_-_101017594 | 4.52 |
ENSMUST00000102694.4
|
Ptgfrn
|
prostaglandin F2 receptor negative regulator |
chr9_-_61854050 | 4.49 |
ENSMUST00000034815.9
|
Kif23
|
kinesin family member 23 |
chr9_-_110572694 | 4.47 |
ENSMUST00000196057.2
|
Pth1r
|
parathyroid hormone 1 receptor |
chr3_-_132655954 | 4.46 |
ENSMUST00000042744.16
ENSMUST00000117811.8 |
Npnt
|
nephronectin |
chr16_+_33504829 | 4.44 |
ENSMUST00000152782.8
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr14_+_69846927 | 4.40 |
ENSMUST00000100420.4
|
Loxl2
|
lysyl oxidase-like 2 |
chr17_+_35643853 | 4.40 |
ENSMUST00000113879.4
|
H2-Q6
|
histocompatibility 2, Q region locus 6 |
chr1_-_133352115 | 4.40 |
ENSMUST00000153799.8
|
Sox13
|
SRY (sex determining region Y)-box 13 |
chr8_-_12722099 | 4.39 |
ENSMUST00000000776.15
|
Tubgcp3
|
tubulin, gamma complex associated protein 3 |
chr1_-_55127312 | 4.36 |
ENSMUST00000127861.8
ENSMUST00000144077.3 |
Hspd1
|
heat shock protein 1 (chaperonin) |
chr2_+_130137068 | 4.34 |
ENSMUST00000110288.9
|
Ebf4
|
early B cell factor 4 |
chr1_-_52271455 | 4.34 |
ENSMUST00000114512.8
|
Gls
|
glutaminase |
chr6_-_52181393 | 4.31 |
ENSMUST00000048794.7
|
Hoxa5
|
homeobox A5 |
chr9_+_106245792 | 4.31 |
ENSMUST00000172306.3
|
Dusp7
|
dual specificity phosphatase 7 |
chr19_+_59249316 | 4.30 |
ENSMUST00000026084.5
|
Slc18a2
|
solute carrier family 18 (vesicular monoamine), member 2 |
chr9_-_61854036 | 4.30 |
ENSMUST00000214295.2
|
Kif23
|
kinesin family member 23 |
chr2_-_65069383 | 4.30 |
ENSMUST00000155916.8
ENSMUST00000156643.2 |
Cobll1
|
Cobl-like 1 |
chr8_-_58106057 | 4.29 |
ENSMUST00000034021.12
|
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7 |
chr5_+_8848138 | 4.27 |
ENSMUST00000009058.10
|
Abcb1b
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
chr12_-_36206750 | 4.26 |
ENSMUST00000221388.2
|
Bzw2
|
basic leucine zipper and W2 domains 2 |
chr3_+_31149201 | 4.24 |
ENSMUST00000118470.8
ENSMUST00000029194.12 ENSMUST00000123532.2 |
Skil
|
SKI-like |
chr17_+_35643818 | 4.24 |
ENSMUST00000174699.8
|
H2-Q6
|
histocompatibility 2, Q region locus 6 |
chr13_+_30320446 | 4.23 |
ENSMUST00000047311.16
|
Mboat1
|
membrane bound O-acyltransferase domain containing 1 |
chr2_-_65069065 | 4.22 |
ENSMUST00000112431.8
|
Cobll1
|
Cobl-like 1 |
chr15_-_100534733 | 4.21 |
ENSMUST00000066068.7
ENSMUST00000229965.2 ENSMUST00000172334.9 |
Smagp
|
small cell adhesion glycoprotein |
chr4_-_128699838 | 4.18 |
ENSMUST00000106072.9
ENSMUST00000170934.3 |
Zfp362
|
zinc finger protein 362 |
chr4_-_136563154 | 4.16 |
ENSMUST00000105846.9
ENSMUST00000059287.14 ENSMUST00000105845.9 |
Ephb2
|
Eph receptor B2 |
chr17_+_35482063 | 4.15 |
ENSMUST00000172503.3
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr6_-_31540913 | 4.13 |
ENSMUST00000026698.8
|
Podxl
|
podocalyxin-like |
chr12_-_15866763 | 4.11 |
ENSMUST00000020922.8
ENSMUST00000221215.2 ENSMUST00000221518.2 |
Trib2
|
tribbles pseudokinase 2 |
chr11_+_105183463 | 4.10 |
ENSMUST00000100335.10
ENSMUST00000021038.5 |
Mrc2
|
mannose receptor, C type 2 |
chr14_-_70414236 | 4.09 |
ENSMUST00000153735.8
|
Pdlim2
|
PDZ and LIM domain 2 |
chr11_+_85723377 | 4.08 |
ENSMUST00000000095.7
|
Tbx2
|
T-box 2 |
chr7_+_86895996 | 4.08 |
ENSMUST00000068829.13
|
Nox4
|
NADPH oxidase 4 |
chr11_-_52173391 | 4.07 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr2_+_117942357 | 4.06 |
ENSMUST00000039559.9
|
Thbs1
|
thrombospondin 1 |
chr15_-_79326311 | 4.05 |
ENSMUST00000230942.2
|
Csnk1e
|
casein kinase 1, epsilon |
chr5_-_77555881 | 4.04 |
ENSMUST00000163898.6
ENSMUST00000046746.10 |
Igfbp7
|
insulin-like growth factor binding protein 7 |
chr5_-_37494213 | 4.04 |
ENSMUST00000031005.11
|
Evc
|
EvC ciliary complex subunit 1 |
chr13_+_91609169 | 4.03 |
ENSMUST00000004094.15
ENSMUST00000042122.15 |
Ssbp2
|
single-stranded DNA binding protein 2 |
chr1_-_134006847 | 4.03 |
ENSMUST00000020692.7
|
Btg2
|
BTG anti-proliferation factor 2 |
chr11_-_98436626 | 4.02 |
ENSMUST00000103141.4
|
Ikzf3
|
IKAROS family zinc finger 3 |
chr11_-_30218167 | 4.02 |
ENSMUST00000006629.14
|
Sptbn1
|
spectrin beta, non-erythrocytic 1 |
chr7_-_19504446 | 4.00 |
ENSMUST00000003061.14
|
Bcam
|
basal cell adhesion molecule |
chr1_+_157286124 | 4.00 |
ENSMUST00000193791.6
ENSMUST00000046743.11 ENSMUST00000119891.7 |
Cryzl2
|
crystallin zeta like 2 |
chrX_+_139565657 | 3.99 |
ENSMUST00000112990.8
ENSMUST00000112988.8 |
Mid2
|
midline 2 |
chr6_-_72765935 | 3.97 |
ENSMUST00000114053.9
|
Tcf7l1
|
transcription factor 7 like 1 (T cell specific, HMG box) |
chr6_-_83433357 | 3.96 |
ENSMUST00000186548.7
|
Tet3
|
tet methylcytosine dioxygenase 3 |
chr4_-_141966662 | 3.96 |
ENSMUST00000036476.10
|
Kazn
|
kazrin, periplakin interacting protein |
chr17_-_57064516 | 3.94 |
ENSMUST00000044752.6
|
Nrtn
|
neurturin |
chr2_-_173117936 | 3.94 |
ENSMUST00000139306.2
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1 |
chr7_-_70010341 | 3.93 |
ENSMUST00000032768.15
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr2_-_173118315 | 3.93 |
ENSMUST00000036248.13
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1 |
chr6_-_134543876 | 3.93 |
ENSMUST00000032322.15
ENSMUST00000126836.4 |
Lrp6
|
low density lipoprotein receptor-related protein 6 |
chr15_-_97729341 | 3.93 |
ENSMUST00000079838.14
ENSMUST00000118294.8 |
Hdac7
|
histone deacetylase 7 |
chr12_+_105529382 | 3.93 |
ENSMUST00000001652.7
|
Bdkrb2
|
bradykinin receptor, beta 2 |
chr4_-_129436465 | 3.91 |
ENSMUST00000102597.5
|
Hdac1
|
histone deacetylase 1 |
chr17_-_17845293 | 3.90 |
ENSMUST00000041047.4
|
Lnpep
|
leucyl/cystinyl aminopeptidase |
chr5_-_37494179 | 3.89 |
ENSMUST00000114148.2
|
Evc
|
EvC ciliary complex subunit 1 |
chr12_+_85646162 | 3.88 |
ENSMUST00000050687.14
|
Jdp2
|
Jun dimerization protein 2 |
chr2_+_83554868 | 3.88 |
ENSMUST00000111740.9
|
Itgav
|
integrin alpha V |
chr16_-_21980200 | 3.86 |
ENSMUST00000115379.2
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr6_+_29735666 | 3.84 |
ENSMUST00000001812.5
|
Smo
|
smoothened, frizzled class receptor |
chr11_+_69656797 | 3.84 |
ENSMUST00000108642.8
ENSMUST00000156932.8 |
Zbtb4
|
zinc finger and BTB domain containing 4 |
chr6_-_148847633 | 3.83 |
ENSMUST00000132696.8
|
Sinhcaf
|
SIN3-HDAC complex associated factor |
chr12_+_31123860 | 3.82 |
ENSMUST00000041133.10
|
Fam110c
|
family with sequence similarity 110, member C |
chr1_+_63215976 | 3.82 |
ENSMUST00000129339.8
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2 |
chr1_-_74990821 | 3.81 |
ENSMUST00000164097.4
|
Ihh
|
Indian hedgehog |
chr8_-_13544478 | 3.79 |
ENSMUST00000033828.7
|
Gas6
|
growth arrest specific 6 |
chr15_+_4056103 | 3.79 |
ENSMUST00000138927.2
|
Oxct1
|
3-oxoacid CoA transferase 1 |
chr19_-_3956991 | 3.79 |
ENSMUST00000126070.9
ENSMUST00000001801.11 |
Tcirg1
|
T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
chr8_+_57964956 | 3.78 |
ENSMUST00000210871.2
|
Hmgb2
|
high mobility group box 2 |
chr8_-_41827639 | 3.78 |
ENSMUST00000034000.15
ENSMUST00000143057.2 |
Asah1
|
N-acylsphingosine amidohydrolase 1 |
chr1_-_98023321 | 3.78 |
ENSMUST00000058762.15
ENSMUST00000097625.10 |
Pam
|
peptidylglycine alpha-amidating monooxygenase |
chr11_+_82842921 | 3.78 |
ENSMUST00000108158.9
ENSMUST00000067443.10 |
Slfn5
|
schlafen 5 |
chr8_+_75720286 | 3.77 |
ENSMUST00000211863.2
|
Hmgxb4
|
HMG box domain containing 4 |
chr13_-_111945499 | 3.77 |
ENSMUST00000109267.9
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1 |
chr10_-_66932615 | 3.76 |
ENSMUST00000217841.2
|
Reep3
|
receptor accessory protein 3 |
chr12_-_36206780 | 3.76 |
ENSMUST00000223382.2
ENSMUST00000020856.6 |
Bzw2
|
basic leucine zipper and W2 domains 2 |
chr3_-_108934916 | 3.74 |
ENSMUST00000171143.2
|
Fam102b
|
family with sequence similarity 102, member B |
chr15_-_98507913 | 3.73 |
ENSMUST00000226500.2
ENSMUST00000227501.2 |
Adcy6
|
adenylate cyclase 6 |
chrX_-_7537580 | 3.72 |
ENSMUST00000033486.6
|
Plp2
|
proteolipid protein 2 |
chr16_+_91203123 | 3.71 |
ENSMUST00000023691.12
|
Il10rb
|
interleukin 10 receptor, beta |
chr8_+_4276827 | 3.71 |
ENSMUST00000053035.7
|
Lrrc8e
|
leucine rich repeat containing 8 family, member E |
chr7_+_134272395 | 3.71 |
ENSMUST00000211593.2
ENSMUST00000084488.5 |
Dock1
|
dedicator of cytokinesis 1 |
chr18_-_53551127 | 3.68 |
ENSMUST00000025419.9
|
Ppic
|
peptidylprolyl isomerase C |
chr14_-_77274056 | 3.67 |
ENSMUST00000062789.15
|
Lacc1
|
laccase domain containing 1 |
chr11_-_117859997 | 3.67 |
ENSMUST00000054002.4
|
Socs3
|
suppressor of cytokine signaling 3 |
chr15_-_100534572 | 3.66 |
ENSMUST00000230280.2
|
Smagp
|
small cell adhesion glycoprotein |
chr3_-_84489923 | 3.65 |
ENSMUST00000143514.3
|
Arfip1
|
ADP-ribosylation factor interacting protein 1 |
chr13_+_34186346 | 3.65 |
ENSMUST00000021844.15
|
Ripk1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1 |
chr2_+_52747855 | 3.65 |
ENSMUST00000155586.9
ENSMUST00000090952.11 ENSMUST00000127122.9 ENSMUST00000049483.14 ENSMUST00000050719.13 |
Fmnl2
|
formin-like 2 |
chr7_-_24950145 | 3.64 |
ENSMUST00000116343.3
ENSMUST00000045847.15 |
Erf
|
Ets2 repressor factor |
chr6_-_124733441 | 3.64 |
ENSMUST00000088357.12
|
Atn1
|
atrophin 1 |
chr12_-_87435091 | 3.64 |
ENSMUST00000021424.5
|
Sptlc2
|
serine palmitoyltransferase, long chain base subunit 2 |
chrX_-_93166992 | 3.63 |
ENSMUST00000088102.12
ENSMUST00000113927.8 |
Zfx
|
zinc finger protein X-linked |
chr1_+_182236728 | 3.63 |
ENSMUST00000117245.2
|
Trp53bp2
|
transformation related protein 53 binding protein 2 |
chr7_-_89166781 | 3.63 |
ENSMUST00000041761.7
|
Prss23
|
protease, serine 23 |
chr9_+_92339422 | 3.62 |
ENSMUST00000034941.9
|
Plscr4
|
phospholipid scramblase 4 |
chr1_-_131995564 | 3.62 |
ENSMUST00000160656.8
ENSMUST00000161864.2 ENSMUST00000126927.8 ENSMUST00000159038.8 |
Mfsd4a
|
major facilitator superfamily domain containing 4A |
chr10_-_75768302 | 3.62 |
ENSMUST00000120281.8
ENSMUST00000000924.13 |
Mmp11
|
matrix metallopeptidase 11 |
chr11_-_100741550 | 3.61 |
ENSMUST00000004143.3
|
Stat5b
|
signal transducer and activator of transcription 5B |
chr10_-_126896024 | 3.60 |
ENSMUST00000040307.6
|
Marchf9
|
membrane associated ring-CH-type finger 9 |
chr18_+_70701260 | 3.60 |
ENSMUST00000074058.11
ENSMUST00000114946.4 |
Mbd2
|
methyl-CpG binding domain protein 2 |
chr11_-_120881904 | 3.59 |
ENSMUST00000070575.14
|
Csnk1d
|
casein kinase 1, delta |
chr6_-_72766224 | 3.59 |
ENSMUST00000069536.12
|
Tcf7l1
|
transcription factor 7 like 1 (T cell specific, HMG box) |
chr6_-_128339458 | 3.58 |
ENSMUST00000155573.3
|
Rhno1
|
RAD9-HUS1-RAD1 interacting nuclear orphan 1 |
chr15_+_89383799 | 3.57 |
ENSMUST00000109309.9
|
Shank3
|
SH3 and multiple ankyrin repeat domains 3 |
chr6_+_91955820 | 3.57 |
ENSMUST00000089334.9
|
Fgd5
|
FYVE, RhoGEF and PH domain containing 5 |
chrX_+_55777139 | 3.56 |
ENSMUST00000023854.10
ENSMUST00000114769.9 |
Fhl1
|
four and a half LIM domains 1 |
chr4_-_150087587 | 3.56 |
ENSMUST00000084117.13
|
H6pd
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
chr13_+_45543208 | 3.56 |
ENSMUST00000038275.11
|
Mylip
|
myosin regulatory light chain interacting protein |
chr1_+_132226308 | 3.55 |
ENSMUST00000046071.5
|
Klhdc8a
|
kelch domain containing 8A |
chr10_-_4337435 | 3.55 |
ENSMUST00000100077.5
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr4_-_155306992 | 3.55 |
ENSMUST00000084103.10
ENSMUST00000030917.6 |
Ski
|
ski sarcoma viral oncogene homolog (avian) |
chr10_-_4338032 | 3.54 |
ENSMUST00000100078.10
|
Zbtb2
|
zinc finger and BTB domain containing 2 |
chr11_-_30148230 | 3.54 |
ENSMUST00000102838.10
|
Sptbn1
|
spectrin beta, non-erythrocytic 1 |
chr7_-_70009669 | 3.53 |
ENSMUST00000208081.2
|
Nr2f2
|
nuclear receptor subfamily 2, group F, member 2 |
chr5_-_65855199 | 3.53 |
ENSMUST00000031104.7
|
Pds5a
|
PDS5 cohesin associated factor A |
chr3_-_132655804 | 3.53 |
ENSMUST00000117164.8
ENSMUST00000093971.5 ENSMUST00000042729.16 |
Npnt
|
nephronectin |
chr3_+_31149247 | 3.52 |
ENSMUST00000117728.8
|
Skil
|
SKI-like |
chr8_+_82069177 | 3.51 |
ENSMUST00000213285.2
ENSMUST00000217122.2 ENSMUST00000215332.2 |
Inpp4b
|
inositol polyphosphate-4-phosphatase, type II |
chr8_-_84467798 | 3.51 |
ENSMUST00000075843.13
ENSMUST00000109802.3 ENSMUST00000166939.8 ENSMUST00000002964.14 |
Adgre5
|
adhesion G protein-coupled receptor E5 |
chr10_-_12745109 | 3.51 |
ENSMUST00000218635.2
|
Utrn
|
utrophin |
chr13_+_91609264 | 3.51 |
ENSMUST00000231481.2
|
Ssbp2
|
single-stranded DNA binding protein 2 |
chr5_+_123532819 | 3.51 |
ENSMUST00000111596.8
ENSMUST00000068237.12 |
Mlxip
|
MLX interacting protein |
chr2_+_5850053 | 3.50 |
ENSMUST00000127116.7
ENSMUST00000194933.2 |
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr19_+_7394951 | 3.50 |
ENSMUST00000159348.3
|
2700081O15Rik
|
RIKEN cDNA 2700081O15 gene |
chr6_-_86770504 | 3.50 |
ENSMUST00000204441.3
ENSMUST00000204398.2 ENSMUST00000001187.15 |
Anxa4
|
annexin A4 |
chr6_+_56809044 | 3.48 |
ENSMUST00000031795.8
|
Fkbp9
|
FK506 binding protein 9 |
chr6_-_37419030 | 3.44 |
ENSMUST00000041093.6
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr2_+_16361582 | 3.43 |
ENSMUST00000114703.10
|
Plxdc2
|
plexin domain containing 2 |
chr17_-_45884179 | 3.43 |
ENSMUST00000165127.8
ENSMUST00000166469.8 ENSMUST00000024739.14 |
Hsp90ab1
|
heat shock protein 90 alpha (cytosolic), class B member 1 |
chr5_+_124583524 | 3.43 |
ENSMUST00000100709.7
|
Kmt5a
|
lysine methyltransferase 5A |
chr15_-_102154874 | 3.43 |
ENSMUST00000063339.14
|
Rarg
|
retinoic acid receptor, gamma |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.6 | GO:0003017 | lymph circulation(GO:0003017) |
3.2 | 9.7 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
3.0 | 8.9 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
2.9 | 2.9 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
2.8 | 14.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
2.8 | 8.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.8 | 8.4 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
2.7 | 2.7 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
2.5 | 7.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.5 | 9.8 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.4 | 7.2 | GO:0015881 | creatine transport(GO:0015881) |
2.4 | 9.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.4 | 11.8 | GO:0044849 | estrous cycle(GO:0044849) |
2.3 | 7.0 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
2.3 | 9.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
2.3 | 9.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.3 | 6.8 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
2.3 | 2.3 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
2.2 | 8.8 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
2.1 | 2.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
2.1 | 2.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
2.1 | 10.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
2.1 | 8.5 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
2.1 | 14.5 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
2.0 | 8.2 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
2.0 | 6.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
2.0 | 6.0 | GO:0021682 | nerve maturation(GO:0021682) |
2.0 | 2.0 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.9 | 7.7 | GO:1902896 | terminal web assembly(GO:1902896) |
1.9 | 5.8 | GO:0001966 | thigmotaxis(GO:0001966) |
1.9 | 5.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.9 | 5.6 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
1.9 | 5.6 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
1.8 | 5.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
1.8 | 5.5 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
1.8 | 1.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
1.8 | 5.4 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
1.8 | 9.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.7 | 8.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
1.7 | 5.2 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
1.7 | 8.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.7 | 6.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.7 | 6.6 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.7 | 5.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.6 | 4.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.6 | 4.8 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
1.6 | 8.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 6.3 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
1.6 | 4.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.6 | 9.3 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
1.6 | 1.6 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.5 | 1.5 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
1.5 | 9.2 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
1.5 | 4.6 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
1.5 | 4.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.5 | 4.4 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.5 | 4.4 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
1.4 | 4.3 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
1.4 | 4.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.4 | 4.3 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
1.4 | 1.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.4 | 7.0 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
1.4 | 2.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.4 | 5.5 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.4 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.4 | 6.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.4 | 4.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
1.3 | 5.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.3 | 8.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.3 | 1.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
1.3 | 4.0 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.3 | 5.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
1.3 | 7.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
1.3 | 5.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.3 | 5.2 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.3 | 6.5 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.3 | 5.2 | GO:0032329 | serine transport(GO:0032329) |
1.3 | 3.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
1.3 | 3.8 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
1.3 | 12.6 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
1.3 | 8.8 | GO:0007527 | adult somatic muscle development(GO:0007527) |
1.3 | 11.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.2 | 5.0 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
1.2 | 3.7 | GO:1901080 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) positive regulation of hindgut contraction(GO:0060450) regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
1.2 | 7.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.2 | 2.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.2 | 4.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
1.2 | 11.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.2 | 4.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.2 | 1.2 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
1.2 | 4.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.2 | 5.9 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
1.2 | 4.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.2 | 14.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.2 | 9.4 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 4.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.2 | 12.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.2 | 1.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
1.1 | 3.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
1.1 | 3.4 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.1 | 2.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.1 | 3.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.1 | 8.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.1 | 2.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 4.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.1 | 5.5 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.1 | 2.2 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
1.1 | 4.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.1 | 7.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.1 | 3.3 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
1.1 | 8.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 5.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 5.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.1 | 3.2 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
1.1 | 6.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.1 | 6.5 | GO:0015889 | cobalamin transport(GO:0015889) |
1.1 | 3.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.1 | 34.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.1 | 5.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.0 | 9.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.0 | 14.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
1.0 | 12.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.0 | 4.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.0 | 4.2 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.0 | 3.1 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
1.0 | 1.0 | GO:0021502 | neural fold elevation formation(GO:0021502) |
1.0 | 5.2 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
1.0 | 8.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.0 | 3.1 | GO:0072347 | response to anesthetic(GO:0072347) |
1.0 | 6.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
1.0 | 6.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.0 | 2.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 7.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.0 | 3.0 | GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000299) |
1.0 | 3.0 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.0 | 17.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 3.0 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
1.0 | 3.0 | GO:0031591 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
1.0 | 3.0 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
1.0 | 7.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.0 | 1.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.0 | 6.8 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.0 | 4.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.0 | 2.9 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.0 | 3.9 | GO:0046722 | lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
1.0 | 3.9 | GO:0045399 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) cellular response to molecule of fungal origin(GO:0071226) |
1.0 | 5.8 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.0 | 5.8 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.0 | 3.8 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.0 | 3.8 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
1.0 | 4.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.0 | 2.9 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.9 | 3.8 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.9 | 1.9 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.9 | 2.8 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.9 | 2.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.9 | 3.8 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.9 | 1.9 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.9 | 4.7 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
0.9 | 12.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.9 | 7.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.9 | 0.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.9 | 4.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.9 | 4.6 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.9 | 0.9 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.9 | 6.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.9 | 5.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.9 | 4.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.9 | 1.8 | GO:0061724 | lipophagy(GO:0061724) |
0.9 | 8.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 3.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.9 | 23.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.9 | 3.6 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.9 | 7.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.9 | 0.9 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.9 | 6.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.9 | 3.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.9 | 6.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.9 | 1.8 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.9 | 7.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.9 | 3.5 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.9 | 3.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.9 | 3.5 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.9 | 12.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 6.9 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.9 | 2.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.9 | 1.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 2.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.9 | 10.4 | GO:0035878 | nail development(GO:0035878) |
0.9 | 4.3 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.9 | 2.6 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.9 | 6.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.9 | 2.6 | GO:1900020 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 3.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.9 | 3.4 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.9 | 1.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.9 | 0.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.9 | 5.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.9 | 1.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 2.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.8 | 2.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.8 | 1.7 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.8 | 8.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 4.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 5.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.8 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.8 | 3.3 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.8 | 3.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.8 | 1.6 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 7.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.8 | 3.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.8 | 4.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.8 | 3.3 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 1.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 3.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.8 | 4.1 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.8 | 2.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.8 | 8.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.8 | 2.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.8 | 3.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 5.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.8 | 4.0 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.8 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.8 | 8.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.8 | 2.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 2.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.8 | 3.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 4.7 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.8 | 2.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.8 | 2.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.8 | 3.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.8 | 2.3 | GO:0072301 | posterior mesonephric tubule development(GO:0072166) metanephric comma-shaped body morphogenesis(GO:0072278) negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.8 | 4.6 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 2.3 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.8 | 3.9 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.8 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.8 | 4.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.8 | 6.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 1.5 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 6.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 2.3 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.8 | 6.1 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.8 | 3.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.8 | 1.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.8 | 0.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.8 | 3.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 6.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.8 | 2.3 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.8 | 3.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.7 | 2.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.7 | 5.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 4.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.7 | 1.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.7 | 3.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.7 | 2.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.7 | 0.7 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.7 | 8.8 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.7 | 1.5 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.7 | 2.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.7 | 2.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 2.2 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.7 | 2.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 2.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.7 | 4.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.7 | 2.8 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.7 | 2.1 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.7 | 2.8 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.7 | 2.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.7 | 2.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.7 | 3.5 | GO:0010157 | response to chlorate(GO:0010157) |
0.7 | 2.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 6.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.7 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.7 | 3.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.7 | 1.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 1.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.7 | 1.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.7 | 22.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.7 | 2.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.7 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 3.4 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.7 | 4.0 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.7 | 11.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.7 | 2.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 5.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 10.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 2.7 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
0.7 | 2.6 | GO:0015904 | tetracycline transport(GO:0015904) |
0.7 | 2.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.7 | 0.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.7 | 2.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.7 | 2.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 0.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.7 | 1.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.7 | 5.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.7 | 2.0 | GO:0016131 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.7 | 3.9 | GO:0035860 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 13.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.6 | 7.8 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.6 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 1.9 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
0.6 | 3.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 0.6 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
0.6 | 1.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.6 | 4.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.6 | 3.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.6 | 3.2 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.6 | 5.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 2.5 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.6 | 3.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.6 | 2.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.6 | 1.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.6 | 2.5 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.6 | 1.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.6 | 2.5 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.6 | 3.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 1.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.6 | 1.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.6 | 4.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.6 | 1.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.6 | 2.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 2.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.6 | 3.0 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.6 | 4.9 | GO:0031179 | peptide modification(GO:0031179) |
0.6 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 3.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.6 | 5.4 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) |
0.6 | 10.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.6 | 1.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.6 | 1.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.6 | 4.2 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.6 | 4.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.6 | 4.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 1.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 2.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 5.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 4.1 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.6 | 4.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 7.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.6 | 2.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.6 | 1.7 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.6 | 1.7 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.6 | 3.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.6 | 1.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.6 | 3.4 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.6 | 2.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.6 | 1.1 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.6 | 5.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 2.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.6 | 2.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.6 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.6 | 4.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.6 | 0.6 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 4.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 8.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 3.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.6 | 1.7 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.6 | 1.7 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.6 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.6 | 1.7 | GO:1903699 | tarsal gland development(GO:1903699) |
0.6 | 2.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 13.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.5 | 3.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.5 | 4.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 2.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 2.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.5 | 13.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.5 | 2.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.5 | 1.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.5 | 2.7 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.5 | 4.3 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 4.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 1.1 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
0.5 | 2.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 5.9 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.5 | 2.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 2.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.5 | 2.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.5 | 18.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 6.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 3.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.5 | 1.6 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 2.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 3.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.5 | 1.6 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.5 | 2.6 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 5.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 2.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 4.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 3.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 9.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.5 | 2.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 6.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 4.6 | GO:0018158 | protein oxidation(GO:0018158) |
0.5 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 2.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 8.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.5 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 1.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 6.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 2.5 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.5 | 3.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.5 | 1.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.5 | 2.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.5 | 8.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 3.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.5 | 14.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 2.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 5.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 2.5 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.5 | 13.4 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.5 | 2.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.5 | 1.5 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.5 | 7.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.5 | 5.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 2.5 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.5 | 1.0 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.5 | 2.0 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.5 | 4.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 1.5 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.5 | 5.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 2.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 2.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 1.0 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.5 | 3.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.5 | 1.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 0.5 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.5 | 1.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.5 | 1.0 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.5 | 3.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 4.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 1.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 8.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.5 | 1.9 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 8.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.4 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.5 | 11.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.5 | 4.2 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.5 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 1.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 0.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 1.4 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
0.5 | 1.9 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 4.1 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.5 | 7.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 6.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.5 | 5.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.9 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.5 | 1.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.5 | 3.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.5 | 0.5 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.5 | 10.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 0.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.5 | 1.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 1.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 3.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 1.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 4.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 0.4 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.4 | 1.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 1.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.4 | 1.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.4 | 1.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 2.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 1.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.4 | 1.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 9.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.4 | 0.9 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 2.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 11.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.8 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 5.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.4 | 2.6 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 0.9 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.4 | 1.3 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.4 | 2.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.4 | 2.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.4 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.4 | 14.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.4 | 1.7 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.4 | 1.7 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.4 | 2.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 3.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.4 | 0.4 | GO:0051794 | regulation of catagen(GO:0051794) |
0.4 | 1.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.4 | 9.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 5.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 3.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.4 | 16.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 4.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.4 | 0.9 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.4 | 1.7 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.4 | 0.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 8.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 1.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 6.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.4 | 3.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.4 | 0.8 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.4 | 3.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 2.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 3.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 0.4 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.4 | 2.9 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 3.7 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 2.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.4 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 1.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.4 | 2.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 1.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 3.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.4 | 1.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.4 | 3.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 2.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 2.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.4 | 11.3 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 4.4 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.4 | 1.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 2.0 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 10.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 1.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 2.8 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 3.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 0.8 | GO:0043144 | snoRNA processing(GO:0043144) |
0.4 | 1.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 2.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 1.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 2.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 1.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 2.0 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.4 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.4 | 1.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 2.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.4 | 4.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.4 | 1.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 2.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 5.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.4 | 1.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 | 1.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.4 | 1.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.4 | 1.2 | GO:2000407 | regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.4 | 3.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 2.3 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.4 | 1.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 28.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.4 | 2.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 3.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.1 | GO:0002604 | regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.4 | 1.1 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.4 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 2.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 1.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 1.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 6.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.4 | 1.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 2.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 1.1 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.4 | 3.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 1.1 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.4 | 4.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.4 | 1.1 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.4 | 1.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.4 | 1.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.4 | 0.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.4 | 7.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 1.8 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.4 | 3.3 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 2.9 | GO:0008228 | opsonization(GO:0008228) |
0.4 | 1.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.4 | 0.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.4 | 1.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 1.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 5.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.4 | 1.8 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 1.8 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.4 | 1.1 | GO:1904629 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
0.4 | 5.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.1 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.4 | 5.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 3.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 1.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 1.4 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 2.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.4 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 6.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 14.4 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.4 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 10.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.3 | 3.1 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.3 | 2.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 5.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 2.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.3 | 6.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 0.7 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.3 | 7.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 8.2 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.7 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.3 | 2.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 6.8 | GO:0031297 | replication fork processing(GO:0031297) |
0.3 | 1.0 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.3 | 0.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 7.8 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.3 | 1.0 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.3 | 5.7 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 0.3 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.3 | 2.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 1.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.3 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.3 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 3.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 3.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 6.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.3 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 2.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.3 | 1.0 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 1.0 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 2.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 2.3 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.3 | 0.6 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 1.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.3 | 1.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 2.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 2.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 1.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 9.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 7.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 7.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 5.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.3 | 20.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 15.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.9 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.3 | 1.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 0.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 1.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.3 | 6.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 1.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 4.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 8.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 1.2 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 1.2 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.9 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 2.1 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.3 | 0.9 | GO:0061723 | glycophagy(GO:0061723) |
0.3 | 2.7 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 3.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 4.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 8.7 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.3 | 0.3 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 0.9 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.3 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 2.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 2.1 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.3 | 2.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.3 | 1.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 2.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 2.6 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 1.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 3.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.6 | GO:0097205 | renal filtration(GO:0097205) |
0.3 | 5.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 2.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 11.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 2.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 3.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 2.0 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.3 | 1.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 0.3 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.3 | 0.6 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.3 | 4.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 2.9 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 0.6 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.3 | 2.3 | GO:0098751 | osteoclast development(GO:0036035) bone cell development(GO:0098751) |
0.3 | 0.6 | GO:0036166 | DNA methylation on cytosine within a CG sequence(GO:0010424) phenotypic switching(GO:0036166) |
0.3 | 1.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 4.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.3 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 2.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 2.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 3.6 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 1.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 0.8 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
0.3 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.6 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 2.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.3 | 0.8 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 1.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 1.4 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 0.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 1.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 1.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.3 | 1.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.3 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 4.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.3 | 3.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 4.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.3 | 1.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 3.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.1 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 2.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 1.6 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.3 | 1.3 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.3 | 1.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 0.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.3 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.3 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.3 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 2.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 20.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.3 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 3.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.3 | 1.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 11.6 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 1.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 2.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.0 | GO:0071404 | cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 2.5 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 2.0 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 1.5 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 4.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.7 | GO:0016246 | RNA interference(GO:0016246) |
0.2 | 4.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 6.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 1.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 3.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 1.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 2.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.7 | GO:1990428 | miRNA transport(GO:1990428) |
0.2 | 2.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 2.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 3.4 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.2 | 9.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 2.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 5.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.0 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 1.2 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 2.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 1.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.2 | 2.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.7 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 3.8 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.4 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 3.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 3.8 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.2 | 1.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 5.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 4.2 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 3.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 3.0 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 1.4 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 1.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 2.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 9.8 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.2 | 1.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 2.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 1.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 2.4 | GO:0060746 | parental behavior(GO:0060746) |
0.2 | 0.2 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.2 | 3.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 4.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 5.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.2 | 1.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 2.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.2 | 1.9 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.2 | 1.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.9 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 1.7 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.2 | 2.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 5.4 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 7.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.6 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.2 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.8 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 0.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.2 | 3.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 3.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.2 | 10.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.2 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 2.8 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.2 | 2.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 1.0 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
0.2 | 1.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.6 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 1.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 2.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.2 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.6 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 2.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 3.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 1.9 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 1.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 4.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.8 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 3.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 1.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 3.6 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.2 | 2.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 3.7 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 5.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 2.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 4.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.2 | 1.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 2.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 0.9 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 4.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 6.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 2.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 1.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.5 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.2 | 1.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
0.2 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 3.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 2.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 1.0 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.7 | GO:2000525 | type IV hypersensitivity(GO:0001806) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 2.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 1.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 2.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 2.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 1.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 4.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 1.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 5.8 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.2 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.2 | 0.5 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.6 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.2 | 1.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 1.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 1.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.8 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.2 | 0.5 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 2.4 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.2 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 2.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 1.3 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 4.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.2 | 2.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.5 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 2.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 3.4 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.2 | 1.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.9 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 4.0 | GO:0007099 | centriole replication(GO:0007099) |
0.2 | 1.4 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 5.6 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.9 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.5 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.2 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.4 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.1 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 3.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.9 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 22.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 3.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 2.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 3.7 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 3.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.8 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 1.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 2.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.0 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 4.5 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 1.4 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 1.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 1.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 3.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.5 | GO:0015808 | aromatic amino acid transport(GO:0015801) L-alanine transport(GO:0015808) tryptophan transport(GO:0015827) |
0.1 | 0.7 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 3.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.4 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.8 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.1 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.6 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 1.4 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.2 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 1.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 1.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 1.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 3.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.1 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 0.3 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.5 | GO:0035268 | protein mannosylation(GO:0035268) |
0.1 | 0.3 | GO:0009107 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
0.1 | 0.7 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 1.7 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 2.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 3.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 6.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 5.6 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 4.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 2.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.1 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 1.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.6 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.1 | 0.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
0.1 | 0.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.5 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.6 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.4 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.3 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.5 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 2.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.3 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 4.2 | GO:0051250 | negative regulation of lymphocyte activation(GO:0051250) |
0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 1.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.8 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 2.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0035037 | sperm entry(GO:0035037) |
0.1 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.1 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 2.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 3.9 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.6 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
0.1 | 1.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.7 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.3 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.0 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 3.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.3 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 8.3 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 1.0 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.1 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 1.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 1.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 7.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.9 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 1.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 1.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.1 | 2.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.2 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 5.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
0.0 | 0.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 1.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.7 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.4 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 1.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 | 0.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0030719 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.0 | 0.1 | GO:0032655 | interleukin-12 production(GO:0032615) regulation of interleukin-12 production(GO:0032655) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 1.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.0 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.0 | 0.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.0 | 0.3 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.1 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.3 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.8 | 11.1 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) |
2.5 | 7.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
2.0 | 8.1 | GO:0001740 | Barr body(GO:0001740) |
2.0 | 10.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
2.0 | 11.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 9.3 | GO:0045160 | myosin I complex(GO:0045160) |
1.8 | 5.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.8 | 7.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.6 | 3.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.6 | 6.3 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
1.6 | 3.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
1.4 | 19.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.3 | 5.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
1.2 | 3.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.2 | 33.1 | GO:0070938 | contractile ring(GO:0070938) |
1.1 | 10.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 5.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.1 | 4.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
1.1 | 8.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.1 | 3.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.1 | 16.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.1 | 5.4 | GO:0043293 | apoptosome(GO:0043293) |
1.1 | 6.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.0 | 3.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
1.0 | 10.3 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 9.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.0 | 2.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 3.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.0 | 4.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
1.0 | 15.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.0 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
1.0 | 4.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.9 | 1.9 | GO:0000805 | X chromosome(GO:0000805) |
0.9 | 6.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.9 | 8.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.9 | 3.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.9 | 4.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 3.6 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.9 | 3.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.9 | 5.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.9 | 4.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.9 | 2.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.9 | 3.5 | GO:0035101 | FACT complex(GO:0035101) |
0.9 | 2.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.9 | 3.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.9 | 2.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.9 | 1.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 2.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.8 | 2.5 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.8 | 4.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 2.5 | GO:0034455 | t-UTP complex(GO:0034455) |
0.8 | 4.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 2.4 | GO:1990879 | CST complex(GO:1990879) |
0.8 | 4.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.8 | 3.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 5.5 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 3.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.8 | 5.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 9.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 63.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.8 | 4.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 3.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.7 | 5.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 12.3 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 2.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.7 | 5.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.7 | 1.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 5.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 2.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.7 | 19.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 2.0 | GO:0034657 | GID complex(GO:0034657) |
0.7 | 6.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.7 | 6.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 15.3 | GO:0042581 | specific granule(GO:0042581) |
0.7 | 2.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.7 | 5.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 1.3 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 3.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 3.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 3.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.6 | 1.9 | GO:1903754 | cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
0.6 | 5.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 11.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.6 | 1.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.6 | 0.6 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 3.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 14.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 6.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 4.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 1.8 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.6 | 1.8 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.6 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 7.5 | GO:0042555 | MCM complex(GO:0042555) |
0.6 | 4.6 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.6 | 3.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.6 | 3.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 2.3 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.6 | 6.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 2.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.6 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 10.0 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 10.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.5 | 2.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.5 | 8.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 1.6 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.5 | 2.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 3.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.1 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.5 | 2.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.5 | 1.5 | GO:0060187 | cell pole(GO:0060187) |
0.5 | 10.3 | GO:0005605 | basal lamina(GO:0005605) |
0.5 | 2.6 | GO:0044307 | dendritic branch(GO:0044307) |
0.5 | 3.6 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 3.6 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 19.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 5.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 4.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 5.9 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 2.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.5 | 1.5 | GO:0002095 | caveolar macromolecular signaling complex(GO:0002095) |
0.5 | 0.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.5 | 13.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 18.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 2.7 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 2.3 | GO:0031251 | PAN complex(GO:0031251) |
0.4 | 1.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.8 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 12.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 4.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 21.7 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 1.3 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.4 | 0.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.4 | 11.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 6.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 2.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.4 | 1.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 7.6 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 3.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 4.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 3.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.4 | 2.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 4.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 3.3 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 12.6 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 7.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.4 | 4.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 3.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 2.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 3.2 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 23.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 24.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 3.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 3.1 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.4 | 5.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.4 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 5.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 1.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.4 | 3.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.4 | 0.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.4 | 4.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 6.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 3.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 5.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.2 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 2.2 | GO:0034448 | EGO complex(GO:0034448) |
0.4 | 0.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.4 | 2.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.4 | 4.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 46.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 181.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 3.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 4.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0000811 | GINS complex(GO:0000811) |
0.3 | 2.4 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.3 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.3 | 2.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) USH2 complex(GO:1990696) |
0.3 | 0.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.3 | 5.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 4.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.3 | 1.9 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 2.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 34.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 1.6 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 2.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 1.3 | GO:1990597 | parallel fiber(GO:1990032) AIP1-IRE1 complex(GO:1990597) |
0.3 | 1.2 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 5.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 1.2 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 19.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 3.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 2.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 0.6 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.3 | 9.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 0.8 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.3 | 15.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.3 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.3 | 14.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 4.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 3.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 0.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 3.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 3.9 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 16.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 3.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 4.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 6.1 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 2.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 8.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 5.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 4.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.7 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.2 | 12.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 13.6 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 11.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 28.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 24.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 5.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 2.5 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 3.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 18.7 | GO:0005901 | caveola(GO:0005901) |
0.2 | 1.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 17.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.2 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 4.2 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.4 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 63.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 8.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 3.9 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 3.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 2.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 1.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 5.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.4 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 2.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 2.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 3.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 8.5 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 68.2 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 1.7 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 4.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.5 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 1.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 2.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 4.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 4.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.6 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 3.9 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 11.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 2.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 2.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 5.7 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 4.1 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 12.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 5.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 5.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 5.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 11.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 7.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 1.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 2.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 60.3 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 16.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 3.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.1 | 2.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 3.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 2.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 8.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 7.6 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 21.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 13.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 2.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 35.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 2.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 2.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 1.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 245.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 5.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 2.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 3.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 3.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 4.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 4.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 2.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0060473 | cortical granule(GO:0060473) |
0.0 | 3.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.0 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.0 | 3.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 11.5 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 11.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 6.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.7 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.9 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 1.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
2.7 | 8.1 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
2.5 | 7.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
2.4 | 7.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
2.2 | 11.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.1 | 21.5 | GO:0038132 | neuregulin binding(GO:0038132) |
2.1 | 10.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
2.1 | 6.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
2.0 | 7.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.9 | 13.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.9 | 5.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
1.9 | 5.6 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
1.8 | 5.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
1.8 | 5.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.8 | 5.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.8 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.8 | 7.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
1.8 | 5.3 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
1.7 | 10.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.6 | 6.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.6 | 6.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.6 | 11.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.6 | 4.8 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
1.6 | 4.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.5 | 7.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.5 | 4.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
1.5 | 4.5 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
1.5 | 4.4 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.5 | 5.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.4 | 10.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.4 | 5.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 8.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
1.4 | 8.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.4 | 4.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.4 | 8.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.3 | 5.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.3 | 5.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.3 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.3 | 8.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.3 | 5.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.3 | 12.5 | GO:0005113 | patched binding(GO:0005113) |
1.3 | 10.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.3 | 3.8 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
1.2 | 6.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 10.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 5.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
1.2 | 4.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.2 | 11.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.2 | 2.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
1.2 | 16.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.2 | 4.6 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.2 | 11.6 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 3.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 4.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.1 | 19.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.1 | 5.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.1 | 5.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
1.1 | 3.2 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.1 | 6.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.1 | 3.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
1.1 | 3.2 | GO:0016015 | morphogen activity(GO:0016015) |
1.1 | 12.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.1 | 3.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.1 | 4.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.0 | 4.2 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.0 | 9.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.0 | 3.1 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
1.0 | 7.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.0 | 3.0 | GO:1902121 | lithocholic acid binding(GO:1902121) |
1.0 | 4.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.0 | 5.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.0 | 6.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 4.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.0 | 2.9 | GO:0003896 | DNA primase activity(GO:0003896) |
1.0 | 2.9 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
1.0 | 3.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.0 | 3.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.9 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.9 | 3.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 2.8 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.9 | 20.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 3.6 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.9 | 4.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.9 | 3.6 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.9 | 5.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 4.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 3.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.9 | 3.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.9 | 2.6 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.9 | 2.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 2.6 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
0.8 | 16.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 3.4 | GO:0019809 | spermidine binding(GO:0019809) |
0.8 | 5.9 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.8 | 14.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 5.8 | GO:0002135 | CTP binding(GO:0002135) |
0.8 | 2.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.8 | 2.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.8 | 2.4 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.8 | 0.8 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
0.8 | 7.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 24.8 | GO:0043236 | laminin binding(GO:0043236) |
0.8 | 1.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 2.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.8 | 4.6 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.8 | 6.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 3.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.8 | 1.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.8 | 3.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.8 | 2.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.8 | 3.0 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
0.8 | 6.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 2.3 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.8 | 3.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.7 | 5.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 2.2 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.7 | 3.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.7 | 2.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.7 | 5.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.7 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 2.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 13.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 8.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
0.7 | 2.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.7 | 3.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 2.1 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.7 | 2.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.7 | 4.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 2.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.7 | 4.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.7 | 2.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.7 | 4.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.7 | 4.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.7 | 4.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 2.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.7 | 6.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 2.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.7 | 12.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.7 | 3.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 2.0 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.6 | 3.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 1.9 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.6 | 1.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.6 | 13.6 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 9.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 1.9 | GO:0001761 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.6 | 13.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.6 | 1.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 2.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 26.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.6 | 6.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 1.9 | GO:0071820 | N-box binding(GO:0071820) |
0.6 | 6.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 3.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.6 | 5.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 6.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 1.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.6 | 7.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 12.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 3.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 3.6 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 2.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.6 | 2.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 4.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.6 | 2.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 1.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.6 | 2.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 3.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 1.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.6 | 1.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.6 | 24.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 1.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.6 | 2.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.6 | 3.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 1.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.6 | 8.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.6 | 2.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.6 | 1.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.6 | 2.3 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.6 | 2.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.6 | 3.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 2.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.6 | 12.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 2.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 4.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.6 | 1.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.6 | 2.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 3.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 12.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 5.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.5 | 3.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 2.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 10.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 5.4 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 14.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 2.7 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 5.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 16.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.5 | 4.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 3.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 3.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 4.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 5.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.5 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 2.6 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.5 | 6.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 4.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.5 | 4.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 2.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 2.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.5 | 2.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.5 | 17.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 0.5 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.5 | 1.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 1.5 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.5 | 2.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 11.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 8.0 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 1.5 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 21.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 1.0 | GO:0070976 | TIR domain binding(GO:0070976) |
0.5 | 2.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 2.0 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.5 | 3.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.5 | 2.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.5 | 4.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 15.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 3.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.5 | 6.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 2.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.5 | 1.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.5 | 3.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 5.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 1.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.5 | 1.9 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 1.9 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.5 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 3.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 2.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 1.4 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 2.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 7.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 10.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 1.4 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.5 | 4.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.5 | 6.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 0.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 1.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.5 | 2.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 1.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 7.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 0.9 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.5 | 7.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 1.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 0.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.5 | 4.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.5 | 0.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 2.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 0.9 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.4 | 1.8 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.4 | 0.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 3.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 1.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.4 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 2.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 2.6 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 2.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 1.3 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 11.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.7 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.4 | 2.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 3.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 1.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.4 | 7.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 5.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 2.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 2.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 14.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 4.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 2.0 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.4 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 4.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.2 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.4 | 2.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.4 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 4.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 0.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 74.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 6.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 1.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 2.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 2.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.4 | 1.2 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.4 | 1.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.4 | 5.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.4 | 2.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.4 | 1.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 3.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 0.8 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.4 | 1.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 2.7 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.4 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 5.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.4 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.4 | 1.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 1.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 6.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 2.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 9.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 1.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 3.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.4 | 3.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 4.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 2.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.4 | 1.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 9.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 3.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 7.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 4.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.4 | 4.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 1.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.4 | 4.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 16.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 11.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 0.7 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 1.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 10.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.4 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 19.2 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.3 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 4.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 3.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 18.8 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 0.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.3 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 8.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 2.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 4.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 1.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.3 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 1.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 3.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 5.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 5.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 6.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 2.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 3.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 5.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 35.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 1.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.3 | 4.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.9 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.3 | 0.9 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.3 | 3.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 4.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 4.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 4.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.3 | 1.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.9 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.3 | 1.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 14.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 1.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 2.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 11.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 2.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 1.2 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.3 | 4.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 2.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 2.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 3.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 0.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 3.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 11.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 9.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 1.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 3.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 6.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 4.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 7.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 3.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 45.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 2.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 6.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 1.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 9.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 3.5 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 4.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.3 | 4.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 9.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 2.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 3.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 7.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 3.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.8 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.3 | 11.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 5.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 3.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 0.8 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.3 | 0.8 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.3 | 1.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.3 | 0.8 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.3 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 2.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.7 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.7 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 1.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 1.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 3.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 1.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.2 | 2.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 1.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 2.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 3.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 7.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 4.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 18.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 3.0 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 7.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.2 | GO:0070540 | stearic acid binding(GO:0070540) |
0.2 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 0.9 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.2 | 2.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 1.9 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 10.9 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 3.2 | GO:0016895 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.2 | 1.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 2.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 0.8 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.2 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 10.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 0.8 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.2 | 4.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 2.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 11.4 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 4.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.2 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.2 | 47.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 13.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.8 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.2 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.8 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 6.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 3.5 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 63.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 7.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 21.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.2 | 1.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 10.9 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 1.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.5 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 1.0 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 4.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.3 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 0.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 2.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 2.9 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.2 | GO:0015292 | uniporter activity(GO:0015292) |
0.2 | 4.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.5 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.2 | 16.9 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 3.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 2.0 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.2 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 4.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 0.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 4.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 2.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.5 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 3.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.1 | 11.9 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 1.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 2.7 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 3.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0008775 | acetate CoA-transferase activity(GO:0008775) |
0.1 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 1.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 6.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 2.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 3.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 2.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 4.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 8.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 3.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 13.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 4.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.1 | 0.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 1.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 3.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.4 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 1.1 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 4.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.8 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.3 | GO:0015924 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.8 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 1.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 2.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 17.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 15.4 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 1.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.4 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 2.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.6 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 3.8 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 1.6 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 12.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 9.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.2 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.1 | 2.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 2.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 1.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 37.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0009881 | G-protein coupled photoreceptor activity(GO:0008020) photoreceptor activity(GO:0009881) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.0 | 0.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 5.0 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.1 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 1.2 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.4 | GO:0015925 | beta-galactosidase activity(GO:0004565) galactosidase activity(GO:0015925) |
0.0 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 6.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 4.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 2.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.5 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0070061 | 6-phosphofructokinase activity(GO:0003872) fructose binding(GO:0070061) |
0.0 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 2.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 7.2 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.0 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0046977 | TAP binding(GO:0046977) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 12.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.1 | 18.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.0 | 4.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.0 | 34.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 37.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 10.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.9 | 7.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.8 | 12.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 12.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 37.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.8 | 3.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 17.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 28.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 34.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 27.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.6 | 3.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 15.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 10.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 12.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 14.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 4.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.6 | 44.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 21.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 23.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 30.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 24.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 27.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.5 | 5.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 6.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 4.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 31.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 21.0 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 8.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 15.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 5.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 5.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 12.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 9.1 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 6.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 23.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 9.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.4 | 8.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 4.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 5.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 26.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 8.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 2.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 11.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 8.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 8.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 28.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 7.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 23.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 6.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 8.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 9.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 28.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 2.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 12.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 1.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 13.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 14.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 4.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 7.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 7.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 3.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 11.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 5.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 6.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 18.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 4.4 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 10.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 7.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 58.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 4.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 2.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 5.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 2.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 9.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 6.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 10.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 15.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 3.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 8.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 12.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 5.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 4.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 5.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 11.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 5.6 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 7.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 15.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 30.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 4.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 6.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 22.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 3.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.7 | 1.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.3 | 1.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.3 | 13.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.3 | 3.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.3 | 21.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.2 | 15.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.0 | 1.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
1.0 | 16.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 13.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 30.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 12.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.7 | 90.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 4.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.7 | 32.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.7 | 6.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.7 | 1.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.7 | 15.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.6 | 3.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.6 | 4.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.6 | 15.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.6 | 10.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 3.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.6 | 9.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.6 | 0.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.6 | 4.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 4.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 6.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.6 | 10.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 20.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 7.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 12.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 15.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 7.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 22.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 4.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 2.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 16.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 1.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 4.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 2.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.5 | 11.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 20.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 14.3 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 6.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 9.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 7.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.4 | 47.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 8.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 8.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 2.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 3.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 5.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 6.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 5.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 26.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 18.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 7.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 15.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 11.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 13.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 3.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 5.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 29.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.4 | 4.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 10.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 12.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.4 | 3.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 9.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 6.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 6.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 3.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 11.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 0.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 8.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 10.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 13.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 44.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 2.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 19.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 13.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 2.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 7.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 5.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 19.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 8.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 26.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 6.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 5.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.3 | 4.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 9.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 10.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 6.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 8.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 8.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 2.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 15.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 6.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 2.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 2.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 2.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 9.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 9.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 5.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 18.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 3.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 6.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 22.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 31.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 3.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 5.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 16.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 2.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 4.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 1.8 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 9.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 5.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 3.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 7.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 5.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 6.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 5.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 3.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 12.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 3.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 3.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 7.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 4.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.8 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 7.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 3.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 5.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 8.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 3.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.4 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 4.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.7 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.1 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 5.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 6.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |